Professor Erika Lietzan recently served as a panelist at the Supreme Court IP Review held at the Chicago-Kent College of Law. She discussed Sandoz, Inc. v. Amgen. Inc., a case decided by the Supreme Court last June. In October 2014, Amgen, a biopharmaceutical company which manufactures Neupogen, an innovative bone marrow stimulant, sued Sandoz, a biopharmaceutical company which manufactures Zarxio,…
Category: Center for Intellectual Property and Entrepreneurship ⋅ Page 17
Professor Lambert Presents to Northwestern Law Faculty
Professor Thom Lambert recently served as the featured speaker for the faculty colloquium at Northwestern University’s Pritzker School of Law. The subject of the colloquium was his recently published book, How to Regulate: A Guide for Policymakers. The book, which examines the tradeoffs policymakers must confront in addressing market failures, sets forth a practical approach to regulating so as to…
Pan American Journal of Public Health Publishes Letter from Professor Lietzan
The Pan American Journal of Public Health published a letter from Professor Erika Lietzan, in which she responds to an article about Colombia’s pathways for approval of biosimilar biologics. A 2014 presidential decree in Colombia allowed for three pathways to market for biologics, and the earlier article, written by the country’s Minister of Health and Social Protection and his colleagues,…
Professor Lietzan testifies before the U.S. House of Representatives Judiciary Committee
Professor Erika Lietzan testified before the House of Representatives Judiciary Committee on July 27, 2017 in a hearing addressing Antitrust Concerns and the FDA Approval Process. Testimony to House of Representatives Judiciary Committee –…